› 4zhl

X-ray diffraction
2.06Å resolution

The crystal structure of mupain-1-IG in complex with murinised human uPA at pH7.4

Released:
DOI: 10.2210/pdb4zhl/pdb
PDB entry 4zhl coloured by chain, front view.
PDB entry 4zhl coloured by chain, side view.
PDB entry 4zhl coloured by chain, top view.
Source organisms:
Primary publication:
Selection of High-Affinity Peptidic Serine Protease Inhibitors with Increased Binding Entropy from a Back-Flip Library of Peptide-Protease Fusions.
Sørensen HP, Xu P, Jiang L, Kromann-Hansen T, Jensen KJ, Huang M, Andreasen PA
J Mol Biol 427 3110-22 (2015)
PMID: 26281711

Function and Biology Details

Reaction catalysed: 
Specific cleavage of Arg-|-Val bond in plasminogen to form plasmin.
Biochemical function:
Biological process:
Cellular component:
  • not assigned
Sequence domains:

Structure analysis Details

Assembly composition:
hetero dimer (preferred)
Assembly name:
PDBe Complex ID:
PDB-CPX-133281 (preferred)
Entry contents:
2 distinct polypeptide molecules
Macromolecules (2 distinct):
Urokinase-type plasminogen activator chain B Chain: U
Molecule details ›
Chain: U
Length: 247 amino acids
Theoretical weight: 27.87 KDa
Source organism: Homo sapiens
Expression system: Komagataella pastoris
UniProt:
  • Canonical: P00749 (Residues: 179-425; Coverage: 60%)
Gene name: PLAU
Sequence domains: Trypsin
Structure domains: Trypsin-like serine proteases
mupain-1-IG Chain: P
Molecule details ›
Chain: P
Length: 10 amino acids
Theoretical weight: 1.13 KDa
Source organism: synthetic construct
Expression system: Not provided

Ligands and Environments

No bound ligands
No modified residues

Experiments and Validation Details

Entry percentile scores
X-ray source: SSRF BEAMLINE BL17U
Spacegroup: R3
Unit cell:
a: 122.057Å b: 122.057Å c: 42.555Å
α: 90° β: 90° γ: 120°
R-values:
R R work R free
0.222 0.22 0.262
Expression systems:
  • Komagataella pastoris
  • Not provided

Quick links

Citations

2 citation in other articles

Design of Specific Serine Protease Inhibitors Based on a Versatile Peptide Scaffold: Conversion of a Urokinase Inhibitor to a Plasma Kallikrein Inhibitor.
Xu et al. (2015)
1 more

1 mention without citation

Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.
Xu et al. (2017)